Abcam Expands Genedata Partnership To Accelerate AI-Driven Antibody Development

01 Abcam expands partnership with Genedata to enhance AI-driven antibody development across global sites.

02 Deploy Genedata Biologics to unify antibody data for improved R&D efficiency and collaboration.

03 Implement centralized platform to streamline workflows in antibody sample management and characterization.

04 Support development of approximately 500 new antibodies annually through enhanced data connectivity.

The full story Abcam Expands Genedata Partnership To Accelerate AI-Driven Antibody Development Read the story